Recruiting

Medtronic MiniMed 780G

Sponsor:

University of Colorado, Denver

Code:

NCT07720388

Conditions

Diabetes Mellitus, Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 10 - 20

Healthy Volunteers: Not accepted

Interventions

Culturally and linguistically tailored onboarding and support program

Medtronic MiniMed 780G Insulin Pump System

Study Details

Brief summary:

This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system.

The main question it aims to answer is:

Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes?

Participants will:

  • Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months
  • Attend one in-person nutrition support and insulin pump start class
  • Participate in regular virtual check-ins with native Spanish-speaking study team members

Conditions

Diabetes Mellitus, Type 1 Diabetes

Study ID

NCT07720388

Start date

Oct 2, 2026

Status verified date

Oct, 2026

Completion date

Oct, 2027

Anticipated

Primary completion date

Jul, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 10 - 20

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 10 - 20 years old
  • Diagnosis of type 1 diabetes
  • Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
  • Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
  • Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study

Exclusion Criteria:

  • Current use of any Medtronic technology
  • More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
  • Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
  • Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation
  • Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

Study Design

Enrollment

15 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Intervention - Medtronic Pump Onboarding Program

Interventions

Culturally and linguistically tailored onboarding and support program

The intervention is a structured, eight-month, culturally and linguistically tailored onboarding and support program for the Medtronic MiniMed 780G system. This includes:

  • Utilization of the Medtronic MiniMed 780G Automated Insulin Delivery system
  • One-on-one nutrition support with a Registered Dietitian
  • A pump start class conducted in Spanish or both English and Spanish for bilingual participants by a Certified Diabetes Educator
  • Virtual check-ins between the participant and study coordinator

Medtronic MiniMed 780G Insulin Pump System

Participants will receive a Medtronic MiniMed 780G Automated Insulin Delivery system, an FDA-approved advanced hybrid closed-loop insulin delivery system that integrates with continuous glucose monitoring technology. A unique feature of the device is its availability with a Spanish-language menu and user interface, which may improve accessibility for Spanish-speaking users and families. Participants will complete standard pump onboarding and training and will use the system as part of their routine diabetes management for up to 8 months.

Primary outcome measure

  • Proportion of Participants Continuing Use of the Medtronic MiniMed 780G System at 6 Months [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Study Coordinator

303-724-4315Karen.Hernandez@cuanschutz.edu

Locations

Barbara Davis Center

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Study Coordinator

303-724-4315Karen.Hernandez@cuanschutz.edu

Principal Investigator:

Andrea Gerard-Gonzalez

More Information

Sponsor

University of Colorado, Denver

Last update posted

Oct 8, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-09. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-10-08. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.